Nuveen Asset Management, LLC Crispr Therapeutics Ag Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 29,503 shares of CRSP stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,503

Previous 26,962 9.42%

Holding current value

$1.57 Million

Previous $1.69 Million 19.15%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $154,162 - $226,453	2,541 Added 9.42%	29,503 $2.01 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $457,531 - $855,116	-11,847 Reduced 30.53%	26,962 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $41,758 - $54,280	920 Added 2.43%	38,809 $1.76 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $1.65 Million - $2.57 Million	37,889 New	37,889 $2.13 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $9.74 Million - $15.5 Million	-138,987 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $726,879 - $1.03 Million	6,596 Added 4.98%	138,987 $15.6 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $2.52 Million - $4.05 Million	25,001 Added 23.28%	132,391 $21.4 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $9,964 - $18,903	90 Added 0.08%	107,390 $13.1 Million
Q4 2020 May 17, 2021	BUY	$79.67 - $173.23 $5.86 Million - $12.7 Million	73,594 Added 218.34%	107,300 $16.4 Million
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $2.49 Million - $5.41 Million	-31,224 Reduced 48.09%	33,706 $5.16 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $3.55 Million - $4.55 Million	45,231 Added 229.61%	64,930 $5.43 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $160,660 - $317,356	-4,173 Reduced 17.48%	19,699 $1.45 Million
Q1 2020 May 14, 2020	SELL	$33.68 - $62.53 $267,722 - $497,050	-7,949 Reduced 24.98%	23,872 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$36.68 - $73.13 $18,156 - $36,199	-495 Reduced 1.53%	31,821 $1.94 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $1.32 Million - $1.7 Million	32,316 New	32,316 $1.33 Million

Others Institutions Holding CRSP

# of Institutions

550

Shares Held

56.3M

Call Options Held

2.91M

Put Options Held

2.47M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.14B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Crispr Therapeutics Ag Transaction History